Agilent Announces Eczema Research Collaboration
Agilent Technology has announced a collaboration with researchers at the University of Sheffield and the University of Manchester to investigate the risk factors surrounding atopic eczema, a chronic skin condition that affects one in five children and one in 12 adults.
Agilent Technology (Santa Clara, California, USA) has announced a collaboration with researchers at the University of Sheffield and the University of Manchester to investigate the risk factors surrounding atopic eczema (atopic dermatitis), a chronic skin condition that affects one in five children and one in 12 adults.
The study will follow a group of 175 babies during their first year of life to see how their skin matures, and identify which babies are most at risk of developing eczema. This early identification is crucial to preventing eczema from developing further, and could also potentially prevent the development of other inflammatory skin disorders.
“A growing body of evidence suggests a critical role for the skin barrier in the development and course of atopic eczema. A greater understanding of skin barrier optimization from birth, promises to identify susceptible individuals early on, and enable novel therapeutic options to improve standards of neonatal skin care and prevent clinical eczema development,” said Simon G. Danby, the lead researcher of the Skin Testing for Atopic eczema Risk (STAR) study and research fellow in the Sheffield Dermatology Research group at the University of Sheffield.
For more information, please visit: www.agilent.com
SPE-Based Method for Detecting Harmful Textile Residues
January 14th 2025University of Valencia scientists recently developed a method using solid-phase extraction (SPE) followed by high-performance liquid chromatography coupled to high-resolution mass spectrometry (HPLC–HRMS/MS) for detecting microplastics and other harmful substances in textiles.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
